Danish Construction Stock News

If you are wondering whether Novo Nordisk shares are offering good value right now, looking at how the current price lines up with different valuation methods can give you a clearer picture. The stock last closed at DKK 378.25, with returns of 3.2% over 7 days, 19.5% over 30 days, 14.5% year to date, a 35.7% decline over 1 year, a 17.2% decline over 3 years, and 85.9% over 5 years. This sets a mixed backdrop for assessing where value might sit today. Recent news around Novo Nordisk has...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

In recent months, GN Store Nord A/S has been working to rebuild its position in audio and hearing technology by tightening costs, integrating operations more effectively, and continuing to develop its Jabra and hearing-aid product lines. This quieter turnaround effort matters because it ties GN’s professional and medical audio strengths directly to persistent trends in remote work and age-driven hearing care demand. We’ll now examine how GN Store Nord’s renewed emphasis on cost savings and...

Those holding Shape Robotics A/S ( CPH:SHAPE ) shares would be relieved that the share price has rebounded 26% in the...

To the annoyance of some shareholders, cBrain A/S ( CPH:CBRAIN ) shares are down a considerable 26% in the last month...

SP Group A/S ( CPH:SPG ) shares have continued their recent momentum with a 26% gain in the last month alone. The last...

With a price-to-earnings (or "P/E") ratio of 41.9x DSV A/S ( CPH:DSV ) may be sending very bearish signals at the...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

You may be wondering if Pandora is starting to look like value after a tough run, or if the risks still outweigh the potential reward for you as a shareholder or watchlist follower. The stock last closed at DKK 588.4, after a 15.4% decline over 7 days, a 16.8% decline over 30 days, a 15.4% decline year to date and a 55.0% decline over the past year, while the 3 year and 5 year returns sit at 10.7% and 6.8% respectively. Recent price moves have come alongside ongoing market attention on...

With a price-to-earnings (or "P/E") ratio of 12.7x Rockwool A/S ( CPH:ROCK B ) may be sending bullish signals at the...

Key Insights Bang & Olufsen's significant retail investors ownership suggests that the key decisions are influenced by...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...

With a price-to-sales (or "P/S") ratio of 3.5x Zealand Pharma A/S ( CPH:ZEAL ) may be sending very bullish signals at...

The main aim of stock picking is to find the market-beating stocks. But the main game is to find enough winners to more...

With a price-to-earnings (or "P/E") ratio of 37.7x Ambu A/S ( CPH:AMBU B ) may be sending very bearish signals at the...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Pandora fair value estimate is kr.1,082 Current share price of...

Key Insights Given the large stake in the stock by institutions, Demant's stock price might be vulnerable to their...

Even if it's not a huge purchase, we think it was good to see that David Hojelsen, the Chief Technology Officer of...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

Brd. Klee A/S ( CPH:KLEE B ) has announced that it will pay a dividend of DKK85.14 per share on the 23rd of January...

Coloplast has recently announced upcoming changes to its Executive Leadership Team, with long-serving leaders in People & Culture and Interventional Urology set to depart and successors, including incoming Interventional Urology head Kevin Hardage from Teleflex, lined up to ensure business continuity. These leadership shifts, particularly in the Interventional Urology division and the global People & Culture function, could influence how effectively Coloplast executes its reorganisation,...

Earlier this week, Danish engineering group FLSmidth was upgraded from "hold" to "buy" by ABG Sundal Collier, with the broker citing expectations of stronger financials, margin expansion and support from higher metal prices as the company exits a major restructuring phase under departing CEO Mikko Keto. The upgrade underscores how FLSmidth’s completed turnaround and exposure to improving metals markets are reshaping expectations for its order pipeline and profitability profile. We’ll now...